Aqua Medical

Venture-backed company · Series B
Rounds on record
1
Latest round
Sep 24, 2026
Series B
More
Ask DFX about thisView relationshipsFinancing historyInvestorsOwnership and outcomes
As of · the latest observation of this company; each round carries its own date

What matters now

  1. Round
    announced

    Announced a Series B on 24 Sep 2026.

    A company that just raised has fresh capital, a new board and new vendors to choose.

    FactPress release wires (PR Newswire, GlobeNewswire)For Investors, lenders, service providersFinancing history →
  2. 2 investors
    named

    2 investors on record; Nashville led a round.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
Drawing the relationship network…
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
1 round
  1. Sep 24, 2026
    Series B · amount undisclosed
    Nashville (lead)Relevance Capital Management, LLC (lead)
    Fact Press release · “Aqua Medical Secures Series B Funding to Advance U.S. Pivotal Trial for Novel Through-the-Scope Type 2 Diabetes Procedure”
Investors on record
2 edges
Ownership and outcomes
none on record
Outcome stated by investors

No firm portfolio page lists this company, so no outcome is stated.

No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.
Credit relationships
none on record
No lender position matched to this company.
People
1 officer, 0 directors
Timeline
1 event
  1. Sep 24, 2026
    Aqua Medical announced Series B, led by Nashville, TN-based Relevance Ventures
    Round announced Fact Press release
Evidence
1 observation
Every observation on this company

Investors it fits

25 scored matches, best firstas of
  • score 38.5confidence 80%
    Why: stage fit; activity
  • score 35.7confidence 80%
    Why: stage fit; activity
  • score 35.7confidence 80%
    Why: stage fit; activity

+22 more investors it fits

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Scored by DFX match engines from the record's observed portfolio, stage, geography and recent activity. A fit is a reason to look, not a mandate; the blockers say what the model could not confirm. Names and the evidence sentences show with the names on this page.

Record history

1 identity change, 1 dated event on the change ledger, latest event first
  • Event dated
    2026-09-24source on record
  • Round announced
    2026-09-24source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.